[grid class='gutter']
[col-3-8]
Regulatory Resources
[/col][col-5-8]
Liposome Drug Products: Guidance for Industry
April 2018 FDA Guidelines
Current Good Manufacturing Practice for Finished Pharmaceuticals (21 CFR Part 211)
Electronic Code of Federal Regulations
[/col][/grid]
[grid class='gutter']
[col-3-8]
Other Resources
[/col][col-5-8]
NIH Office of Rare Diseases Research (ORDR)
Research Tools
NIH Office of Rare Diseases Research (ORDR)
Research Funding Resources
[/col][/grid]
1-317-347-2800